In the future, the group company Resaphene will cooperate with GEHE Pharma Handel in the distribution of the tinnitus therapy device Tinniwell. From August 2018, the Tinniwell will be introduced in the 800 top-selling pharmacies in Germany. In total, GEHE has a network of 7,000 pharmacies that can be reached.
This is another step towards the professionalization of Resaphene’s distribution channel. Currently, 2 additional sales concepts for ENT physicians in Germany and Switzerland are being rolled out.Back